Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivo (Q73068323)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030892%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030892%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

H Q Wu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030892%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

F G Salituro

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030892%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R Schwarcz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030892%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030892%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030892%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

319

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030892%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030892%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

13-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030892%20AND%20SRC:MED&resulttype=core&format=json

Quinolinic acid accumulation and functional deficits following experimental spinal cord injury

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Cloning and functional expression of a soluble form of kynurenine/alpha-aminoadipate aminotransferase from rat kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Anticonvulsant activity of a novel NMDA/glycine site antagonist, MDL 104,653, against kindled and sound-induced seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

The utility of excitatory amino acid (EAA) antagonists as analgesic agents. II. Assessment of the antinociceptive activity of combinations of competitive and non-competitive NMDA antagonists with agents acting at allosteric-glycine and polyamine rec

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

7-Chlorokynurenic acid, a strychnine-insensitive glycine receptor antagonist, inhibits limbic seizure kindling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Protection Against N-methyl-D-aspartate Receptor-Mediated Neuronal Degeneration In Rat Brain by 7-chlorokynurenate and 3-amino-1-hydroxypyrrolid-2-one, Antagonists at The Allosteric Site for Glycine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Blood?Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Facilitated brain uptake of 4-chlorokynurenine and conversion to 7-chlorokynurenic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Glycine potentiates the NMDA response in cultured mouse brain neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

The NMDA antagonist 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) has antinociceptive effect after intrathecal injection in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

3'-(Arylmethyl)- and 3'-(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: orally active antagonists of the glycine site on the NMDA receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Excitatory amino acids as a final common pathway for neurologic disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

3-Phenyl-4-hydroxyquinolin-2(1H)-ones: potent and selective antagonists at the strychnine-insensitive glycine site on the N-methyl-D-aspartate receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Clinical experience with excitatory amino acid antagonist drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Antiepileptogenic action of 7-chlorokynurenic acid on amygdala kindling of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Measurement of rat brain kynurenine aminotransferase at physiological kynurenine concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Glutamate receptor dysfunction and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

An in vivo model for studying function of brain tissue temporarily devoid of glial cell metabolism: the use of fluorocitrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Immunocytochemical localization of kynurenine aminotransferase in the rat striatum: a light and electron microscopic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

The NMDA receptor, NMDA antagonists and epilepsy therapy. A status report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Enzyme-activated antagonists of the strychnine-insensitive glycine/NMDA receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Characterization of human brain kynurenine aminotransferases using [3H]kynurenine as a substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

α-Amino-ω-phosphono carboxylates block ibotenate but not kainate neurotoxicity in rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

High-affinity uptake of L-kynurenine by a Na+-independent transporter of neutral amino acids in astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Anxiolytic properties of 1-aminocyclopropanecarboxylic acid, a ligand at strychnine-insensitive glycine receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

4-Halo-3-hydroxyanthranilic acids: Potent competitive inhibitors of 3-hydroxy-anthranilic acid oxygenase in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

Kynurenic Acid in the Quinolinate-lesioned Rat Hippocampus: Studies In Vitro and In Vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2896%2900829-1

10.1016/S0014-2999(96)00829-1

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9030892%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference